Furthermore, we showed that miR-1249 inhibited CRC growth, metastasis, and angiogenesis by targeting vascular endothelial growth factor A (VEGFA) and high mobility group AT-hook 2 (HMGA2). This evidence concerns the gene HMGA2 and colorectal carcinoma.